Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Spironolactone

Hyperkalaemia following off label use: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Thiede RM, et al. Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program. International Journal of Women's Dermatology 5: 155-157, No. 3, 2019. Available from: URL: http://doi.org/10.1016/j.ijwd.2019.04.024 - USA Thiede RM, et al. Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program. International Journal of Women's Dermatology 5: 155-157, No. 3, 2019. Available from: URL: http://​doi.​org/​10.​1016/​j.​ijwd.​2019.​04.​024 - USA
Metadaten
Titel
Spironolactone
Hyperkalaemia following off label use: 3 case reports
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-66053-6

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Bevacizumab